Quinoline Compound


Disclosed is a novel LXRß agonist which is useful as a prophylactic and/or therapeutic agent for arteriosclerosis such as atherosclerosis and arteriosclerosis associated with diabetes, dyslipidemia, hypercholesterolemia, lipid-related diseases, inflammatory diseases induced by an inflammatory cytokine, skin diseases such as allergic skin diseases, diabetes or Alzheimer's disease.  Specifically disclosed is a quinoline compound represented by general formula (1), a salt thereof, or a solvate of the quinoline compound or the salt.


Download Citation

Sign in to the Lens